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Background: Traditionally, left ventricular systolic dysfunction (sHF) and valvular disorders have been implicated in precipitating pulmonary 
hypertension (sHF-PH). Recently, heart failure with preserved ejection fraction (HFpEF) has been increasingly recognized as a leading cause of PH 
(HFpEF-PH). However, data is sparse comparing the natural history of these two etiologies. We sought to elucidate morbidity and mortality through 5 
years of severe HFpEF-PH compared with sHF-PH in a large medical center in New York City.
Methods: In a retrospective cohort fashion, we identified all patients who, from 2000-2010, were diagnosed with severe PH at Montefiore Medical 
Center via echo (pulmonary artery systolic pressure≥65mmHg, left atrial size≥4cm) at Montefiore Medical Center. Patients were grouped based on 
ejection fraction (EF) ≥50% (HFpEF-PH) or EF≤35% (sHF-PH) with exclusion if they had evidence of recent surgery. Endpoints were all-cause mortality 
and readmission through 5 years.
Results: After multivariate analysis, patients with HFpEF-PH (N=370) exhibited a significantly elevated all cause mortality rate (77%) and mean 
readmission (3.6±0.2) through 5 years compared to the all cause mortality rate (62%, p=0.01; figure A) and mean readmission (2.8±0.2, p=0.01; 
figure B) with sHF-PH (N=272).
Conclusions: Patients with severe HFpEF-PH have a worse prognosis than patients with sHF-PH. This difference should be considered when treating 
HFpEF-PH.
